Telmisartan attenuates the inflamed mesenteric adipose tissue in spontaneous colitis by mechanisms involving regulation of neurotensin/microRNA-155 pathway

Biochemical Pharmacology

Volumn 93, Issue 4, 2015, Pages 461-469

  Li, Yi ^a   Zuo, Lugen ^a   Zhu, Weiming ^a   Gong, Jianfeng ^a   Zhang, Wei ^a   Guo, Zhen ^a   Gu, Lili ^a   Li, Ning ^a   Li, Jieshou ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Crohns disease; Mesenteric adipose tissue; MicroRNA 155; Neurotensin; Telmisartan

Indexed keywords

ADIPOCYTOKINE; INTERLEUKIN 10; MICRORNA 155; NEUROTENSIN; TELMISARTAN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BENZIMIDAZOLE DERIVATIVE; BENZOIC ACID DERIVATIVE; MICRORNA; MIRN155 MICRORNA, MOUSE;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG EFFECT; IN VITRO STUDY; MESENTERIC ADIPOSE TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; C3H MOUSE; DRUG EFFECTS; INFLAMMATION; INTRAABDOMINAL FAT; KNOCKOUT MOUSE; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BENZIMIDAZOLES; BENZOATES; COLITIS; INFLAMMATION; INTRA-ABDOMINAL FAT; MALE; MICE; MICE, INBRED C3H; MICE, KNOCKOUT; MICRORNAS; NEUROTENSIN;

EID: 84922158970     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2014.12.020     Document Type: Article

References (79)

1. S. Danese, and C. Fiocchi Ulcerative colitis N Engl J Med 365 2011 1713 1725
2. C. Fink, I. Karagiannides, K. Bakirtzi, and C. Pothoulakis Adipose tissue and inflammatory bowel disease pathogenesis Inflamm Bowel Dis 18 2012 1550 1557
3. C. Abraham, and J.H. Cho Inflammatory bowel disease N Engl J Med 361 2009 2066 2078
4. P. Desreumaux, O. Ernst, K. Geboes, L. Gambiez, D. Berrebi, and H. Muller-Alouf Inflammatory alterations in mesenteric adipose tissue in Crohn's disease Gastroenterology 117 1999 73 81
5. B.B. Crohn, L. Ginzburg, and G.D. Oppenheimer Landmark article Oct 15, 1932. Regional ileitis. A pathological and clinical entity. By Burril B. Crohn, Leon Ginzburg, and Gordon D. Oppenheimer JAMA 251 1984 73 79
6. G. Maconi, S. Greco, P. Duca, S. Ardizzone, A. Massari, and A. Cassinotti Prevalence and clinical significance of sonographic evidence of mesenteric fat alterations in Crohn's disease Inflamm Bowel Dis 14 2008 1555 1561
7. F.L. Weakley, and R.B. Turnbull Recognition of regional ileitis in the operating room Dis Colon Rectum 14 1971 17 23
8. B. Erhayiem, R. Dhingsa, C.J. Hawkey, and V. Subramanian Ratio of visceral to subcutaneous fat area is a biomarker of complicated Crohn's disease Clin Gastroenterol Hepatol 9 2011 684 687.e1
9. A. Zulian, R. Cancello, G. Micheletto, D. Gentilini, L. Gilardini, and P. Danelli Visceral adipocytes: old actors in obesity and new protagonists in Crohn's disease Gut 61 2012 86 94
10. A. Batra, M. Zeitz, and B. Siegmund Adipokine signaling in inflammatory bowel disease Inflamm Bowel Dis 15 2009 1897 1905
11. L. Peyrin-Biroulet, F. Gonzalez, L. Dubuquoy, C. Rousseaux, C. Dubuquoy, and C. Decourcelle Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease Gut 61 2012 78 85
12. S.C. Benson, H.A. Pershadsingh, C.I. Ho, A. Chittiboyina, P. Desai, and M. Pravenec Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity Hypertension 43 2004 993 1002
13. P. Desreumaux, L. Dubuquoy, S. Nutten, M. Peuchmaur, W. Englaro, and K. Schoonjans Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies J Exp Med 193 2001 827 838
14. C.G. Su, X. Wen, S.T. Bailey, W. Jiang, S.M. Rangwala, and S.A. Keilbaugh A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response J Clin Invest 104 1999 383 389
15. J. Bassaganya-Riera, K. Reynolds, S. Martino-Catt, Y. Cui, L. Hennighausen, and F. Gonzalez Activation of PPAR gamma and delta by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease Gastroenterology 127 2004 777 791
16. C. Lytle, T.J. Tod, K.T. Vo, J.W. Lee, R.D. Atkinson, and D.S. Straus The peroxisome proliferator-activated receptor gamma ligand rosiglitazone delays the onset of inflammatory bowel disease in mice with interleukin 10 deficiency Inflamm Bowel Dis 11 2005 231 243
17. J.P. Berger, A.E. Petro, K.L. Macnaul, L.J. Kelly, B.B. Zhang, and K. Richards Distinct properties and advantages of a novel peroxisome proliferator-activated protein [gamma] selective modulator Mol Endocrinol 17 2003 662 676
18. D. Chujo, K. Yagi, A. Asano, H. Muramoto, S. Sakai, and A. Ohnishi Telmisartan treatment decreases visceral fat accumulation and improves serum levels of adiponectin and vascular inflammation markers in Japanese hypertensive patients Hypertens Res 30 2007 1205 1210
19. K. Murakami, J. Wada, D. Ogawa, C.S. Horiguchi, T. Miyoshi, and M. Sasaki The effects of telmisartan treatment on the abdominal fat depot in patients with metabolic syndrome and essential hypertension: Abdominal fat Depot Intervention Program of Okayama (ADIPO) Diab Vasc Dis Res 10 2013 93 96
20. M. Shimabukuro, H. Tanaka, and T. Shimabukuro Effects of telmisartan on fat distribution in individuals with the metabolic syndrome J Hypertens 25 2007 841 848
21. G. Aubert, M. Burnier, A. Dulloo, C. Perregaux, L. Mazzolai, and F. Pralong Neuroendocrine characterization and anorexigenic effects of telmisartan in diet- and glitazone-induced weight gain Metabolism 59 2010 25 32
22. A. Miesel, H. Muller-Fielitz, O. Johren, F.M. Vogt, and W. Raasch Double blockade of angiotensin II (AT(1))-receptors and ACE does not improve weight gain and glucose homeostasis better than single-drug treatments in obese rats Br J Pharmacol 165 2012 2721 2735
23. F. Younis, N. Stern, R. Limor, Y. Oron, S. Zangen, and T. Rosenthal Telmisartan ameliorates hyperglycemia and metabolic profile in nonobese Cohen-Rosenthal diabetic hypertensive rats via peroxisome proliferator activator receptor-gamma activation Metabolism 59 2010 1200 1209
24. G. Paul, A. Schaffler, M. Neumeier, A. Furst, F. Bataillle, and C. Buechler Profiling adipocytokine secretion from creeping fat in Crohn's disease Inflamm Bowel Dis 12 2006 471 477
25. H. Cui, F. Cai, and D.D. Belsham Anorexigenic hormones leptin, insulin, and alpha-melanocyte-stimulating hormone directly induce neurotensin (NT) gene expression in novel NT-expressing cell models J Neurosci 25 2005 9497 9506
26. H. Cui, F. Cai, and D.D. Belsham Leptin signaling in neurotensin neurons involves STAT, MAP kinases ERK1/2, and p38 through c-Fos and ATF1 FASEB J 20 2006 2654 2656
27. G.M. Leinninger, D.M. Opland, Y.H. Jo, M. Faouzi, L. Christensen, and L.A. Cappellucci Leptin action via neurotensin neurons controls orexin, the mesolimbic dopamine system and energy balance Cell Metab 14 2011 313 323
28. P. Brun, C. Mastrotto, E. Beggiao, A. Stefani, L. Barzon, and G.C. Sturniolo Neuropeptide neurotensin stimulates intestinal wound healing following chronic intestinal inflammation Am J Physiol Gastrointest Liver Physiol 288 2005 G621 G629
29. H.W. Koon, Y.S. Kim, H. Xu, A. Kumar, D. Zhao, and I. Karagiannides Neurotensin induces IL-6 secretion in mouse preadipocytes and adipose tissues during 2,4,6,-trinitrobenzensulphonic acid-induced colitis Proc Natl Acad Sci U S A. 106 2009 8766 8771
30. K. Bakirtzi, M. Hatziapostolou, I. Karagiannides, C. Polytarchou, S. Jaeger, and D. Iliopoulos Neurotensin signaling activates microRNAs-21 and -155 and Akt, promotes tumor growth in mice, and is increased in human colon tumors Gastroenterology 141 2011 1749 1761 e1
31. T. Takagi, Y. Naito, K. Mizushima, I. Hirata, N. Yagi, and N. Tomatsuri Increased expression of microRNA in the inflamed colonic mucosa of patients with active ulcerative colitis J Gastroenterol Hepatol 25 Suppl 1 2010 S129 S133
32. Y. Chen, F. Siegel, S. Kipschull, B. Haas, H. Frohlich, and G. Meister miR-155 regulates differentiation of brown and beige adipocytes via a bistable circuit Nat Commun 4 2013 1769
33. S. Liu, Y. Yang, and J. Wu TNFalpha-induced up-regulation of miR-155 inhibits adipogenesis by down-regulating early adipogenic transcription factors Biochem Biophys Res Commun 414 2011 618 624
34. M. Skarn, H.M. Namlos, P. Noordhuis, M.Y. Wang, L.A. Meza-Zepeda, and O. Myklebost Adipocyte differentiation of human bone marrow-derived stromal cells is modulated by microRNA-155, microRNA-221, and microRNA-222 Stem Cells Dev 21 2012 873 883
35. A. Schaffler, A. Furst, C. Buchler, G. Paul, G. Rogler, and J. Scholmerich Secretion of RANTES (CCL5) and interleukin-10 from mesenteric adipose tissue and from creeping fat in Crohn's disease: regulation by steroid treatment J Gastroenterol Hepatol 21 2006 1412 1418
36. R. Kuhn, J. Lohler, D. Rennick, K. Rajewsky, and W. Muller Interleukin-10-deficient mice develop chronic enterocolitis Cell 75 1993 263 274
37. R.K. Sellon, S. Tonkonogy, M. Schultz, L.A. Dieleman, W. Grenther, and E. Balish Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice Infect Immun 66 1998 5224 5231
38. D. Yen, J. Cheung, H. Scheerens, F. Poulet, T. McClanahan, and B. McKenzie IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6 J Clin Invest 116 2006 1310 1316
39. I.J. Bristol, M.A. Farmer, Y. Cong, X.X. Zheng, T.B. Strom, and C.O. Elson Heritable susceptibility for colitis in mice induced by IL-10 deficiency Inflamm Bowel Dis 6 2000 290 302
40. Y. Li, Y. Tian, W. Zhu, J. Gong, W. Zhang, and C. Yu Triptolide induces suppressor of cytokine signaling-3 expression and promotes lamina propria mononuclear cells apoptosis in Crohn's colitis Int Immunopharmacols 16 2013 268 274
41. Y. Li, C. Yu, W.M. Zhu, Y. Xie, X. Qi, and N. Li Triptolide ameliorates IL-10-deficient mice colitis by mechanisms involving suppression of IL-6/STAT3 signaling pathway and down-regulation of IL-17 Mol Immunol 47 2010 2467 2474
42. W.M. Zhu, Y. Li, C. Yu, N. Li, and J.S. Li Antimouse CD52 monoclonal antibody inhibits established spontaneous colitis in IL-10-deficient mice Inflamm Bowel Dis 17 2011 E72 E73
43. D.M. Spencer, G.M. Veldman, S. Banerjee, J. Willis, and A.D. Levine Distinct inflammatory mechanisms mediate early versus late colitis in mice Gastroenterology 122 2002 94 105
44. K. Araki, T. Masaki, I. Katsuragi, K. Tanaka, T. Kakuma, and H. Yoshimatsu Telmisartan prevents obesity and increases the expression of uncoupling protein 1 in diet-induced obese mice Hypertension 48 2006 51 57
45. P. Rutgeerts, K. Geboes, G. Vantrappen, J. Beyls, R. Kerremans, and M. Hiele Predictability of the postoperative course of Crohn's disease Gastroenterology 99 1990 956 963
46. P. Rutgeerts, K. Geboes, G. Vantrappen, R. Kerremans, J.L. Coenegrachts, and G. Coremans Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery Gut 25 1984 665 672
47. C.P. Sewter, J.E. Digby, F. Blows, J. Prins, and S. O'Rahilly Regulation of tumour necrosis factor-alpha release from human adipose tissue in vitro J Endocrinol 163 1999 33 38
48. K. Yamamoto, T. Kiyohara, Y. Murayama, S. Kihara, Y. Okamoto, and T. Funahashi Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn's disease Gut 54 2005 789 796
49. M. Fujimoto, H. Masuzaki, T. Tanaka, S. Yasue, T. Tomita, and K. Okazawa An angiotensin II AT1 receptor antagonist, telmisartan augments glucose uptake and GLUT4 protein expression in 3T3-L1 adipocytes FEBS Lett 576 2004 492 497
50. D.E. Elliott, T. Setiawan, A. Metwali, A. Blum, J.F. Urban Jr., and J.V. Weinstock Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice Eur J Immunol 34 2004 2690 2698
51. M. Weng, D. Huntley, I.F. Huang, O. Foye-Jackson, L. Wang, and A. Sarkissian Alternatively activated macrophages in intestinal helminth infection: effects on concurrent bacterial colitis J Immunol 179 2007 4721 4731
52. M. Adachi, R. Kurotani, K. Morimura, Y. Shah, M. Sanford, and B.B. Madison Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease Gut 55 2006 1104 1113
53. M. Shiraki, H. Aihara, Y. Kinouchi, S. Takahashi, M. Oki, and M. Noguchi IL-12 p40 prevents the development of chronic enterocolitis in IL-10-deficient mice Lab Invest 84 2004 1491 1500
54. S. Melgar, A. Karlsson, and E. Michaelsson Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation Am J Physiol Gastrointest Liver Physiol 288 2005 G1328 G1338
55. C. Niederau, F. Backmerhoff, and B. Schumacher Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis Hepatogastroenterology 44 1997 90 107
56. H. Kudo, Y. Yata, T. Takahara, K. Kawai, Y. Nakayama, and M. Kanayama Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue Liver Int 29 2009 988 996
57. K. Sugimoto, N.R. Qi, L. Kazdova, M. Pravenec, T. Ogihara, and T.W. Kurtz Telmisartan but not valsartan increases caloric expenditure and protects against weight gain and hepatic steatosis Hypertension 47 2006 1003 1009
58. J.N. Fain, A.K. Madan, M.L. Hiler, P. Cheema, and S.W. Bahouth Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans Endocrinology 145 2004 2273 2282
59. M. Matsubara, S. Maruoka, and S. Katayose Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women Eur J Endocrinol 147 2002 173 180
60. J.A. Sennello, R. Fayad, M. Pini, M.E. Gove, and G. Fantuzzi Transplantation of wild-type white adipose tissue normalizes metabolic, immune and inflammatory alterations in leptin-deficient ob/ob mice Cytokine 36 2006 261 266
61. B. Siegmund, H.A. Lehr, and G. Fantuzzi Leptin: a pivotal mediator of intestinal inflammation in mice Gastroenterology 122 2002 2011 2025
62. B. Siegmund, J.A. Sennello, J. Jones-Carson, F. Gamboni-Robertson, H.A. Lehr, and A. Batra Leptin receptor expression on T lymphocytes modulates chronic intestinal inflammation in mice Gut 53 2004 965 972
63. A. Tsuchida, T. Yamauchi, S. Takekawa, Y. Hada, Y. Ito, and T. Maki Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination Diabetes 54 2005 3358 3370
64. M.R. Hoda, M. Scharl, S.J. Keely, D.F. McCole, and K.E. Barrett Apical leptin induces chloride secretion by intestinal epithelial cells and in a rat model of acute chemotherapy-induced colitis Am J Physiol Gastrointest Liver Physiol 298 2010 G714 G721
65. S. Sitaraman, X. Liu, L. Charrier, L.H. Gu, T.R. Ziegler, and A. Gewirtz Colonic leptin: source of a novel proinflammatory cytokine involved in IBD FASEB J 18 2004 696 698
66. I. Olivier, V. Theodorou, P. Valet, I. Castan-Laurell, H. Guillou, and J. Bertrand-Michel Is Crohn's creeping fat an adipose tissue Inflamm Bowel Dis. 17 2011 747 757
67. K. Karmiris, I.E. Koutroubakis, C. Xidakis, M. Polychronaki, T. Voudouri, and E.A. Kouroumalis Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease Inflamm Bowel Dis 12 2006 100 105
68. M.A. Thomaz, S.C. Acedo, C.C. de Oliveira, J.A. Pereira, D.G. Priolli, and M.J. Saad Methotrexate is effective in reactivated colitis and reduces inflammatory alterations in mesenteric adipose tissue during intestinal inflammation Pharmacol Res 60 2009 341 346
69. T.R. Clemente, A.N. Dos Santos, J.N. Sturaro, E.M. Gotardo, C.C. de Oliveira, and S.C. Acedo Infliximab modifies mesenteric adipose tissue alterations and intestinal inflammation in rats with TNBS-induced colitis Scand J Gastroenterol 47 2012 943 950
70. I. Karagiannides, K. Bakirtzi, and C. Pothoulakis Neuropeptide - adipose tissue communication and intestinal pathophysiology Curr Pharm Des 17 2011 1576 1582
71. X. Luo, L.M. Tsai, N. Shen, and D. Yu Evidence for microRNA-mediated regulation in rheumatic diseases Ann Rheum Dis 69 Suppl. 1 2010 i30 i36
72. R.D. Zipser, J.B. Patterson, H.W. Kao, C.J. Hauser, and R. Locke Hypersensitive prostaglandin and thromboxane response to hormones in rabbit colitis Am J Physiol 249 1985 G457 G463
73. R. Jaszewski, V. Tolia, M.N. Ehrinpreis, J.H. Bodzin, R.R. Peleman, and R. Korlipara Increased colonic mucosal angiotensin I and II concentrations in Crohn's colitis Gastroenterology 98 1990 1543 1548
74. Y. Inokuchi, T. Morohashi, I. Kawana, Y. Nagashima, M. Kihara, and S. Umemura Amelioration of 2,4,6-trinitrobenzene sulphonic acid induced colitis in angiotensinogen gene knockout mice Gut 54 2005 349 356
75. K. Katada, N. Yoshida, T. Suzuki, T. Okuda, K. Mizushima, and T. Takagi Dextran sulfate sodium-induced acute colonic inflammation in angiotensin II type 1a receptor deficient mice Inflamm Res 57 2008 84 91
76. T. Mizushima, M. Sasaki, T. Ando, T. Wada, M. Tanaka, and Y. Okamoto Blockage of angiotensin II type 1 receptor regulates TNF-alpha-induced MAdCAM-1 expression via inhibition of NF-kappaB translocation to the nucleus and ameliorates colitis Am J Physiol Gastrointest Liver Physiol 298 2010 G255 G266
77. M. Okawada, H. Koga, S.D. Larsen, H.D. Showalter, A.J. Turbiak, and X. Jin Use of enterally delivered angiotensin II type Ia receptor antagonists to reduce the severity of colitis Dig Dis Sci 56 2011 2553 2565
78. O.I. Santiago, E. Rivera, L. Ferder, and C.B. Appleyard An angiotensin II receptor antagonist reduces inflammatory parameters in two models of colitis Regul Pept 146 2008 250 259
79. D. Wengrower, G. Zanninelli, O. Pappo, G. Latella, M. Sestieri, and A. Villanova Prevention of fibrosis in experimental colitis by captopril: the role of tgf-beta1 Inflamm Bowel Dis 10 2004 536 545